Golden Gate Private Equity’s Cerence CRNC Stock Holding History

Golden Gate Private Equity’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-64,000	Closed	-$985K	–	25
2020 Q1	$985K	Buy	+64,000	New	+$1.35M	0.46%	24

Other funds holding CRNC

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Golden Gate Private Equity's CRNC Position: Q2 2020 in Review

Golden Gate Private Equity sold out of Cerence (CRNC) in Q2 2020, closing a stake of 64,000 shares — an estimated $985K sold.

Golden Gate Private Equity first reported a position in CRNC in Q1 2020 and held it in 1 quarter. The position peaked at $985K in Q1 2020. 241 funds tracked by Wall St. Rank hold CRNC as of Q2 2020.

Golden Gate Private Equity reported no remaining Cerence position as of Q2 2020 after selling out during the quarter.
Golden Gate Private Equity sold 64,000 Cerence shares in Q2 2020, an estimated $985K.
Golden Gate Private Equity first reported a position in Cerence in Q1 2020 and held it in 1 quarter.
Golden Gate Private Equity's Cerence position peaked at $985K in Q1 2020.
241 funds tracked by Wall St. Rank held Cerence as of Q2 2020.

Based on Golden Gate Private Equity's 13F filing for Q2 2020, filed 14 Aug 2020.